Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
1.220
-0.070 (-5.43%)
At close: Jun 13, 2025, 4:00 PM
1.211
-0.009 (-0.73%)
After-hours: Jun 13, 2025, 6:34 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Cancer Therapeutics
1.89M
Log In
Log In
Cancer Therapeutics Growth
-90.55%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
United States
1.89M
Log In
Log In
United States Growth
-90.55%
Log In
Log In